Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
XA
Xtherapeutics ApS
aktivCVR 37384089AnpartsselskabHovmarksvej 73, 2920 CharlottenlundFremstilling af farmaceutiske præparater
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not disclosed—
Not disclosed
Operating profit
DKK 0
Latest period
Source details
Source: dk-regnskabsdata-live-37384089-1793892133144
Document: dk-regnskabsdata-37384089-AZwfGl6Uzh75jaqyQjAX-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: c0
Unit: u0
Net result
DKK 0
Latest period
Source details
Source: dk-regnskabsdata-live-37384089-1793892133144
Document: dk-regnskabsdata-37384089-AZwfGl6Uzh75jaqyQjAX-1
XBRL: fsa:ProfitLoss
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: c0
Unit: u0
Equity
DKK -18.4k
Latest period
Source details
Source: dk-regnskabsdata-live-37384089-1793892133144
Document: dk-regnskabsdata-37384089-AZwfGl6Uzh75jaqyQjAX-1
XBRL: fsa:Equity
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: c3
Unit: u0
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK -14.4k |
| 2023 | — | DKK -17.1k |
| 2024 | — | DKK -14.3k |
| 2025 | — | DKK 0 |